Corgenix Medical Corporation To Launch New Hepcidin-25 Product At The American Society of Hematology Annual Meeting

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that it will launch the Research-Use-Only (RUO) Hepcidin-25 Chemiluminescent Direct ELISA test kit at the 55th Annual Meeting of the American Society of Hematology (ASH®) at the Ernest N. Morial Convention Center in New Orleans.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC